Lutein

Last Updated: September 28 2022

Lutein, as well as the related zeaxanthin, are carotenoid structures similar to pre-vitamin A (β-carotene) and involved in eye health. A dietary component of eggs, lutein appears to be effective for this claim and a general antioxidant.

Lutein is most often used for

Summary

Lutein is a carotenoid structure similar to Zeaxanthin, and the two are components of many food products such as egg yolks and paprika. Lutein may bioaccumulate in the eyes where it is thought to reduce oxidative stress.

References
2.^Handelman GJ, Nightingale ZD, Lichtenstein AH, Schaefer EJ, Blumberg JBLutein and zeaxanthin concentrations in plasma after dietary supplementation with egg yolkAm J Clin Nutr.(1999 Aug)
3.^Wenzel AJ, Gerweck C, Barbato D, Nicolosi RJ, Handelman GJ, Curran-Celentano JA 12-wk egg intervention increases serum zeaxanthin and macular pigment optical density in womenJ Nutr.(2006 Oct)
4.^Hammond BR Jr, Johnson EJ, Russell RM, Krinsky NI, Yeum KJ, Edwards RB, Snodderly DMDietary modification of human macular pigment densityInvest Ophthalmol Vis Sci.(1997 Aug)
9.^Surai PF, MacPherson A, Speake BK, Sparks NHDesigner egg evaluation in a controlled trialEur J Clin Nutr.(2000 Apr)
10.^Borel P, Grolier P, Mekki N, Boirie Y, Rochette Y, Le Roy B, Alexandre-Gouabau MC, Lairon D, Azais-Braesco VLow and high responders to pharmacological doses of beta-carotene: proportion in the population, mechanisms involved and consequences on beta-carotene metabolismJ Lipid Res.(1998 Nov)
12.^Henderson CT, Mobarhan S, Bowen P, Stacewicz-Sapuntzakis M, Langenberg P, Kiani R, Lucchesi D, Sugerman SNormal serum response to oral beta-carotene in humansJ Am Coll Nutr.(1989 Dec)
13.^Ahmed SS, Lott MN, Marcus DMThe macular xanthophyllsSurv Ophthalmol.(2005 Mar-Apr)
14.^Junghans A, Sies H, Stahl WMacular pigments lutein and zeaxanthin as blue light filters studied in liposomesArch Biochem Biophys.(2001 Jul 15)
15.^la Cour M, Kiilgaard JF, Nissen MHAge-related macular degeneration: epidemiology and optimal treatmentDrugs Aging.(2002)
17.^van Leeuwen R, Boekhoorn S, Vingerling JR, Witteman JC, Klaver CC, Hofman A, de Jong PTDietary intake of antioxidants and risk of age-related macular degenerationJAMA.(2005 Dec 28)
18.^Snellen EL, Verbeek AL, Van Den Hoogen GW, Cruysberg JR, Hoyng CBNeovascular age-related macular degeneration and its relationship to antioxidant intakeActa Ophthalmol Scand.(2002 Aug)
20.^Beatty S, Murray IJ, Henson DB, Carden D, Koh H, Boulton MEMacular pigment and risk for age-related macular degeneration in subjects from a Northern European populationInvest Ophthalmol Vis Sci.(2001 Feb)